Clinical Trials Directory

Trials / Unknown

UnknownNCT04505852

Implementing Artificial-intelligence Wristbands to Help in Recording Seizures

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Taichung Veterans General Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that the participants will be satisfied with artificial-intelligence wristband Embrace

Detailed description

Currently, seizure tracking relies on subjective patient and family recall. In several studies patients report only approximately half of their seizures, and even less during sleep. Sudden unexplained death in epilepsy (SUDEP) is the cause of premature death of up to 17% of all patients with epilepsy and as many as 50% with chronic refractory epilepsy (with rates as high as 1% per year). Its etiology is probably due to peri-ictal respiratory, cardiac, or autonomic nervous system dysfunction. Wristband sensors help caregivers assist patients during seizures and may reduce risks for complications such as injuries and SUDEP. Accurate seizure detection may improve the quality of life (QoL) of subjects and caregivers by decreasing burden of seizure monitoring and may facilitate diagnostic monitoring in the home setting. Possible risks are occurrence of alarm fatigue and invasion of privacy. The wristband Embrace has an overall sensitivity of 89.1% and an overall specificity of 93.1%. The investigators hypothesize that the participants will be satisfied with artificial-intelligence wristband Embrace. Methods: When the smart wristband detects the seizure, the mobile phone sends a text message to the companion and the nurse, the latter will see or get in touch with the companion and keep a record. In-patients receiving video-electroencephalography (VEEG) exam use Embrace during the VEEG recording which usually takes 3-5 days. Out-patients use Embrace for 8 weeks. The investigators will enroll 30-50 patients, half in-patients and half out-patients. The benefits are evaluated in terms of satisfaction. .

Conditions

Interventions

TypeNameDescription
DEVICEEmbracePatients wear Embrace2 to help in seizure reporting and patient care.

Timeline

Start date
2020-03-05
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2020-08-10
Last updated
2022-04-28

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04505852. Inclusion in this directory is not an endorsement.